* Blond McIndoe Centre, Queen Victoria Hospital, East Grinstead, West Sussex RH19 3DZ, United Kingdom; Department of
Biochemistry, Charing Cross and Westminster Medical School, London W6 8RF, United Kingdom; and § Department of Plastic
and Reconstructive Surgery, University College, London W1P 7LD, United Kingdom
The purpose of this study was to evaluate the effect of neurotrophin 3 (NT-3) enhanced nerve regeneration on the reinnervation of a target muscle. Muscle fibers can be classified according to their mechanical properties and myosin heavy chain (MHC) isoform composition. MHC1 containing slow-type and MHC2a or 2b fast-type fibers are normally distributed in a mosaic pattern, their phenotype dictated by motor innervation. After denervation, all fibers switch to fast-type MHC2b expression and also undergo atrophy resulting in loss of muscle mass. After regeneration, discrimination between fast and slow fibers returns, but the distribution and fiber size change according to the level of reinnervation.
In this study, rat gastrocnemius muscles (ipsilateral and contralateral to the side of nerve injury) were collected up to 8 mo after nerve repair, with or without local delivery of NT-3. The phenotype changes of MHC1, 2a, and 2b were analyzed by immunohistochemistry, and fiber type proportion, diameter, and grouping were assessed by computerized image analysis. At 8 mo, the local delivery of NT-3 resulted in significant improvement in gastrocnemius muscle weight compared with controls (NT-3 group 47%, controls 39% weight of contralateral normal muscle; P < 0.05). NT-3 delivery resulted in a significant increase in the proportion (NT-3 43.3%, controls 35.7%; P < 0.05) and diameter (NT-3 87.8 µm, controls 70.8 µm; P < 0.05) of fast type 2b fibers after reinnervation. This effect was specific to type 2b fibers; no normalization was seen in other fiber types.
This study indicates that NT-3-enhanced axonal regeneration has a beneficial effect on the motor target organ. Also, NT-3 may be specifically affecting a subset of motoneurons that determine type 2b muscle fiber phenotype. As NT-3 was topically applied to cut nerves, our data suggest a discriminating effect of the neurotrophin on neuro-muscular interaction. These results would imply that muscle fibers may be differentially responsive to other neurotrophic factors and indicate the potential clinical role of NT-3 in the prevention of muscle atrophy after nerve injury.
THERE has been much recent interest in the use of
growth factors to augment peripheral nerve regeneration. A family of growth factors collectively
known as the neurotrophins are now considered critical
for the development, maintenance, and regeneration of the nervous system. The neurotrophin family includes NGF,
brain derived neurotrophic factor (BDNF), neurotrophin-3
(NT-3),1 and neurotrophin-4/5 (NT-4/5) (Lewin and Barde,
1996 NT-3 has been shown to act on a subpopulation of muscle sensory neurons innervating muscle spindles and Golgi
tendon organs, and there is also evidence of its effect on a
subpopulation of cutaneous afferents (Ernfors et al., 1994 When a skeletal muscle is denervated and subsequently
reinnervated, a characteristic sequence of events ensues.
The muscle rapidly loses weight as the muscle fibers atrophy (Pellegrino and Franzini, 1963 We have recently demonstrated that the local delivery
of NT-3 to rat sciatic nerve enhances the rate and amount
of nerve regeneration, and at 8 mo postoperative, there
was a 40% increase in the myelinated fiber count (Sterne
et al., 1997 Surgical Procedure
8-wk-old inbred male Lewis rats were anesthetized using 0.3 ml/kg of intramuscular Hypnorm (0.315 mg/ml fentanyl citrate and 10 mg/ml fluanisone; Janssen Pharmaceuticals Ltd.) and 2.5 mg/kg of intraperitoneal
diazepam (Phoenix Pharmaceuticals Ltd.).
Using an operating microscope (Wild Heerbrugg Ltd.), the left sciatic
nerve was exposed 5 mm distal to the sciatic notch via a gluteal muscle
splitting incision. A 5-mm length of nerve was removed using sharp microsurgery scissors to produce a gap of 10 mm after retraction of the nerve
ends. This gap was grafted with fibronectin impregnated with 500 ng/ml
NT-3 (NT) (Sterne et al., 1997 During insertion, 14-mm-long fibronectin mats were entubulated, the
hydroscopic nature of the fibronectin causing them to expand, obliterating
the lumen. The proximal and distal nerve stumps were drawn into either
end of the entubulated mat to produce a resultant gap of 10 mm and two
10/0 monofilament nylon (Ethicon Ltd., Edinburgh, UK) interrupted sutures were used at each anastomosis. For autologous nerve grafts, a 1-cm
length of sciatic nerve was removed, reversed, and reanastomosed to bridge
the resulting defect. Animals received postoperative analgesia for 24 h
and were kept warm until fully recovered from the anesthetic before their
return to the holding room, where they had free access to food and water. On the first postoperative day, the animals were caged in groups of three.
Samples from six animals from each group were harvested at 5, 10, 15, 30, 120, and 240 d postoperatively. The animals were killed and the calf
muscles approached by extending the lateral thigh incision beyond the ankle joint. Gastrocnemius muscles were removed bilaterally from each animal. Using an operating microscope, the entire gastrocnemius muscle was
carefully cleaned and dissected out, dividing its two tendinous origins and
tendinous insertion flush with the bone. Each muscle was then weighed
separately to allow calculation of the percentage reduction in muscle mass
(denervated muscle weight vs. contralateral muscle weight) after denervation and reinnervation. For the animals harvested at 240 d only, the effects
of reinnervation on the gastrocnemius muscle were investigated immunohistochemically. To ensure biopsy of a constant part of the muscle, while
holding the knee joint fully extended and the ankle joint flexed to 90°, the
midpoint of the gastrocnemius muscle, lying half way between the knee
and ankle, was identified and marked with a blue surgical marking pen.
The muscles were then harvested as before.
Immunohistochemistry
After weighing, a transverse disc of the whole muscle 5 mm long was cut
and carefully orientated on a small piece of cork to allow transverse sections to be made. The muscle specimen, embedded in OCT, was rapidly
frozen by rapid inversion and plunging into isopentane cooled in liquid nitrogen for about 30 s.
A panel of mouse monoclonal antisera was used for immunostaining,
and it included BA-F8 antibodies raised against rat MHC 1, SC-71 antibodies raised against rat MHC 2a, and BF-F3 antibodies raised against rat
MHC 2b. All primary antibodies were used at a 1:200 dilution in PBS, pH
7.4. Antibodies to the MHCs (Schiaffino et al., 1989 Serial 8-µm transverse cryostat sections were cut from each muscle
block, collected on Vectabond-coated slides (Vector, UK), and air dried
for 30 min at room temperature before immunofluorescent staining. The
sections were permeabilized by immersion in 0.2% Triton X-100 in PBS
(Merck/BDH, UK) for one hour, rinsed three times in PBS, and incubated
in 3% goat serum (TCS Biologicals, UK) in PBS to block any background
binding from the secondary labeled antibody. Sections were then incubated with the primary antibodies for 24 h at 4°C in a humid chamber,
washed in PBS/Tween (0.02%) to remove nonspecifically bound antibody,
rinsed three times in PBS, and incubated with cyanine-3-conjugated goat
anti-mouse serum (Affinity, UK, diluted 1:100 in PBS). Nonspecifically
bound second layer antibodies were again removed by washing with PBS/ Tween, and the sections were then rinsed in PBS and mounted with PBS/
glycerol containing 2.5% (wt/vol) 1,4-diazabicyclo [2.2.2] octane (Aldrich
Chemical, Gillingham, UK) as an antifading agent.
Quantification and Morphometric Analysis
All morphometric measurements were performed on coded sections without knowledge of their source. The sections were viewed using an Olympus (Lake Success, NY) microscope connected to a computerized image
analysis system (Seescan Analytical Services, Cambridge, UK) appropriately calibrated for each objective magnification. Six fields (10x objective)
were chosen at random from each muscle section providing a minimum of
100 positive fibers from each section. After image capture, background
subtraction, image enhancement, thresholding, and final editing, automatic counting and measurement of the diameter of each positive fiber
was performed using a dedicated calibrated software program.
An assessment of the degree of fiber type distribution was performed
by placing a randomly orientated line from an eyepiece graticule across
the entire muscle section, and the number of fibers in each group of positive and negative fibers along this line were recorded. 10 random linear
transects were made on each muscle, counting a minimum of 900 fibers.
These counts were used as a representative indication of the total number
of muscle fibers in each whole muscle section and allowed to quantify the
proportion, diameter, and size distribution of each fiber type in each experimental group.
Statistical Analysis
Statistical analysis was carried out using the STATA (STATA Corporation, College Station, TX) and SIGMASTAT (Jandel Scientific, Erkrath,
Germany) software packages. A one-way analysis of variance (ANOVA)
was used to analyze the results of the muscle masses, fiber type distributions, and diameters. The normality assumption of ANOVA was
checked using Shapiro-Francia's W Effect of NT-3-enhanced Nerve Regeneration on
Muscle Atrophy
The mass of both gastrocnemius muscles in each animal
was recorded to allow calculation of the percentage atrophy (mass of denervated muscle/mass of normal contralateral muscle x 100) in each group at each time point (Fig. 1).
After denervation, initially there was a rapid loss of muscle mass equally in each group up to day 15. By day 30, the
muscles in the groups repaired with fibronectin conduits
continued to lose muscle mass at an equal rate; however,
in the animals repaired with autologous nerve grafts, the
reduction in muscle mass was significantly less (P < 0.05). At subsequent time points, the NT group showed steady
recovery of the muscle mass, which reached 47% of the
weight of contralateral normal muscle at 8 mo. The degree
of recovery of muscle mass was higher after NT-3 administration than in the FN group, which reached only 39% normal muscle weight at the final time point. This difference failed to reach significance at 120 d but was significant at
240 d (P < 0.05). The muscle in the NG group returned to
71% of their original mass by day 120 but remained stable
at this level by day 240 (P < 0.001 NG vs. NT and FN).
Changes in Distribution of Muscle Fiber Types after
Denervation and Reinnervation
Fibers staining positive for MHC 1 were
confined to the deeper third of the contralateral normal
muscle, distributed in a mosaic pattern, and were rarely
seen in the peripheral superficial two thirds of the gastrocnemius muscle. After reinnervation, the distribution of
these groups was much more scattered throughout the
muscle: although MHC 1 staining fibers predominated in
the deeper parts of the muscle, there were considerable
numbers of groups in more superficial regions. There was
no obvious difference between experimental groups in the
redistribution patterns of type 1 fibers after reinnervation.
In normal muscles, MHC 2a staining fibers had a similar distribution to that of MHC 1 fibers,
namely a mosaic distribution within the deep third of the
muscle with few fibers in the superficial two thirds. After
reinnervation, this pattern was disrupted with groups
present throughout the muscle but with a slight preponderance for the deeper parts remaining; again, no obvious
intergroup differences were noted.
Staining for MHC 2b shows a fiber distribution mainly in the superficial two thirds of the gastrocnemius muscle and to a lesser extent in the deep muscle
regions. The usual mosaic distribution pattern was evident
in all areas of the muscle (Fig. 2 a). Reinnervation resulted
in significant disruption of the mosaic pattern (Fig. 2 b),
but the general preponderance of MHC 2b stained fibers
within the superficial two thirds of the muscle persisted; no
difference was evident between experimental groups.
Preferential Effect of NT-3-mediated Reinnervation
on MHC Fiber Type
From 10 transects across the entire section of each muscle,
a minimum of 900 fibers were counted, allowing a comparison of the estimated number of muscle fibers (Table I)
and of the percentage distribution of each fiber type in
each group (Table II). From these counts it was evident
that there was no statistical difference between mean fiber
counts from different groups. An interesting difference in
fiber proportions was noted for type 2b fibers (Table II).
After reinnervation, the percentage of type 2b fibers in the
NT group was similar to that in normal muscle and significantly greater than in either of the NG or FN groups (P < 0.05). In contrast, the type 2b proportion fell significantly
in the NG and FN groups compared with normal muscle
(P < 0.01).
Table I.
The Mean Number of Fibers Counted in 10 Transects
of the Whole Muscle in Each Group
Table II.
The Percentage Distribution of Fiber Types in Each
Group (n = 6)
; Lindsay, 1996
). Little is known of their effect on regeneration of the peripheral nervous system.
;
Tessarolo et al., 1994; Airaksinen et al., 1996
). NT-3 has
shown various effects on motor nerve regeneration, including differentiation of motoneurons from avian neural
tube progenitor cells (Averbuch-Heller et al., 1994
) and
survival of neonatal and adult motoneurons in vitro
(Hughes et al., 1993
) and of neonatal motoneurons in vivo
(Li et al., 1994
; Vejsada et al., 1995
), although the evidence
is sometimes contradictory (Eriksson et al., 1994
). In cocultures of adult muscle and embryonic motoneurons, NT-3
enhances the number and length of neurite outgrowths,
the density of endplates per muscle fiber, and the amount
of muscle innervation (Braun et al., 1996
). NT-3 also plays
a role in functional maturation of neuromuscular synapses
(Lohoff et al., 1993; Wang et al., 1995
) and regulates the
cholinergic phenotype of developing motoneurons (Wong
et al., 1993
; Kato and Lindsay, 1994
). NT-3 knockout mice
show a loss of all muscle spindle afferent innervation and
fusimotor neurons to the muscle but lose only few skeletomotor nerve fibers (Kucera et al., 1995a
). About 80% of
adult motoneurons express the NT-3-specific trkC receptor (Henderson et al., 1993
; Griesbeck et al., 1995
), and
NT-3 is the predominant neurotrophin expressed in skeletal muscle (Griesbeck et al., 1995
). Furthermore, NT-3 is
internalized and retrogradely transported from the periphery to motoneuron cell bodies (Di Stefano et al., 1992).
Thus, there is experimental and circumstantial evidence to
suggest that NT-3 may play a role in adult motoneurons,
although in vivo data on the survival effect of NT-3 on
adult motoneurons is still lacking. Furthermore, there is
no evidence of an NT-3-dependent effect on neuro-muscular interaction.
), but after reinnervation,
it gradually recovers mass to a variable extent, depending
upon the degree of reinnervation (Bertelli and Mira, 1995
)
and correlating with the maximum force of contraction (Gillespie et al., 1987
). The fibers within an individual skeletal
muscle do not exist as a homogenous population but can
be classified according to their different metabolic and contractile properties (Burke et al., 1971
; Peter et al., 1972
). Also, they can be identified morphologically according to
differential expression of specific myosin heavy chain isoforms. Slow, oxidative type 1 muscle fibers contain myosin
heavy chain 1 (MHC 1), fast oxidative glycolytic type 2a
fibers contain myosin heavy chain 2a (MHC 2a), while fast
glycolytic type 2b fibers contain myosin heavy chain 2b
(MHC 2b) (Bar and Pette, 1988
). Muscle fiber phenotype is
conferred by its innervation, and changes of neuro-muscular interaction lead to alteration of muscle fiber phenotype
(Romanul and Van der Meulen, 1966
; Fex and Sonneson,
1970
; Salmons and Sreter, 1975
). The relative proportions
of fiber types vary with age, sex, strain, species, and muscle
type (Maltin et al., 1989
). Generally, there is a high proportion of type 1 fibers in postural muscles (e.g., soleus) and
of type 2 fibers in fast muscles (e.g., extensor digitorum
longus), while in mixed muscles (e.g., gastrocnemius) there
are varying proportions of each type. Muscle fiber type proportion also varies dynamically with physiological and
pathological parameters (Jansson et al., 1978
; Green et al.,
1983
; Izumo et al., 1986
; Goldspink et al., 1992
; Pette and
Vrbova, 1992
). For example, the distribution of fiber types
in normal muscle is dispersed in a "mosaic pattern," but
after denervation and reinnervation of the muscle there is
a shift to grouping (Karpati and Engel, 1968
). Also, there
is a change in the proportions of fiber types, and in the rat
the majority of fibers become initially fast with denervation, with subsequent fiber specialization being dictated by
patterns of reinnervation (Fields and Ellisman, 1986
). This plastic nature of muscle makes it an interesting model to
investigate reinnervation changes that may occur after
NT-3 administration.
). However, enhanced regeneration by itself is
not necessarily indicative of a beneficial effect on the target muscles, such as reacquisition of more normal physiological function. Therefore, the aim of this study was to assess whether NT-3-enhanced nerve regeneration resulted
in biochemical or morphological changes in a target muscle (gastrocnemius), which would be suggestive of significant improvement of physiological function above that seen after nerve repair without administration of neurotrophin. Immunohistochemistry, in conjunction with computerized quantification and morphometrical analysis, was
used to analyze the number, size, and pattern of distribution of the MHC fiber types after denervation and reinnervation of the gastrocnemius muscle.
Materials and Methods
); alternatively plain fibronectin mats (FN)
or autologous nerve grafts (NG) were inserted as controls.
) were supplied by Regeneron Pharmaceuticals, USA.
test and Bartlett's test was used to
check the equal variance assumption. If data violated the assumptions of
normality and variance they were compared using a Kruskal-Wallis one-way ANOVA on ranks, and data was then expressed as the median values
(25th-75th centiles). Differences between individual groups were subsequently isolated by the use of an appropriate all pair-wise multiple comparison procedure. To statistically analyze the size distribution profiles,
the 5th and 95th centiles of each fiber type in normal muscle were calculated and the frequencies and percentages of muscle fibers in each group that were smaller, intermediate, or larger than these centiles were then
compared using Fisher's exact test, introducing a Bonferroni adjustment
to allow for the number of comparisons made.
Results
Fig. 1.
The percentage reduction in gastrocnemius muscle
mass at various times after sciatic nerve division and repair. Each
data point represents the mean of six animals. Error bars show
the standard error of the mean. *P < 0.05 for NG vs. NT and FN,
ANOVA. **P < 0.001 for NG vs. NT and FN, ANOVA. ***P < 0.05 for NT vs. FN, ANOVA. NG, autologous nerve graft repair;
NT, repair with NT-3-impregnated fibronectin mats (500 ng/ml);
FN, repair with plain fibronectin mats.
[View Larger Version of this Image (14K GIF file)]
Fig. 2.
(a) Transverse immunofluorescent sections of normal gastrocnemius muscle stained for MHC 2b, demonstrating the typical
size and mosaic pattern of distribution. (b) 8 mo after repair of a 1-cm-long sciatic nerve defect using a plain fibronectin mat, the MHC
2b immunoreactive fibers are generally smaller, and there is a loss of the mosaic pattern of fiber type distribution. Bar, 50 µm.
[View Larger Version of this Image (45K GIF file)]
The proportion of type 1 muscle fibers fell significantly from normal levels following denervation and reinnervation (P < 0.02), with no differences between experimental groups in the reinnervated muscles. The proportion of type 2a muscle fibers in all experimental groups rose significantly compared with normal after reinnervation (P < 0.01), without differences between the three groups.
NT-3-dependent Changes of Muscle Fiber Morphometry
Consistent with the results of percentage distribution of fiber types, morphometric analysis of muscle fiber diameters showed that type 2b fibers regained normal average size after NT-3-mediated reinnervation (Table III). Conversely, in the two control groups the diameter of type 2b fibers was significantly smaller than in muscle of normal and NT groups (P < 0.01). The diameters of type 2a fibers in reinnervated muscles of all groups were significantly smaller than in normal muscles (P < 0.01). This was also the case for type 1 fibers (P < 0.01), with the exception of the NG group, where they recovered normal size.
Table III. Diameters of the Different Fiber Types in Each Group |
Analysis of distribution profiles of individual muscle fiber diameters (Fig. 3, a-c) showed that the distribution profile of type 2b fibers for the reinnervated NT group closely resembled that seen in control muscle (P = 1, NT vs. control). The distribution profiles for the NG and FN groups contained more small fibers and fewer large fibers, with a pattern different from both control and NT groups. The difference was particularly evident after reinnervation without NT-3 administration (FN group), where there was a statistically significant difference from both control and NT groups (P < 0.005).
Reinnervated muscle in all experimental groups demonstrated a shift towards small type 1 fibers compared with normal muscle, though a few large fibers were still present. Instead, type 2a fibers showed a shift toward intermediate size fibers, with fewer large and small diameter fibers than normal muscle. For both type 1 and 2a fibers, statistical analysis confirmed a significant shift toward smaller sizes (P < 0.005 for each group vs. normal).
Here we present evidence that NT-3 improves motor target organ reinnervation in terms of recovery of both normal proportions of type 2b muscle fibers and their return
to normal diameter. These results are consistent with our
previous report that the local delivery of NT-3 to injured
sciatic nerves in rats enhances both the rate and amount of
axonal regeneration (Sterne et al., 1997).
After denervation, the gastrocnemius muscle was found
to lose weight rapidly, falling to ~30% of its original weight
by day 30, consistent with similar results reported previously (Sunderland, 1978). At day 30, muscles in the NG
group were significantly less atrophic than in both fibronectin groups. It is likely from the results of the regeneration rate in the NG group (Sterne, G.D., unpublished
results) that by day 30 the muscle was already becoming reinnervated. By day 120, the recovery of muscle mass
seen after NT-3 administration was improved compared
with control FN group, although it was still less than after
nerve grafts. The muscle recovery of the NT-3 group was
maintained and actually improved with statistical significance by 8 mo. This correlates well with our previously reported myelinated fiber counts distal to the nerve repair
in which NT-3-impregnated mats supported a significant improvement in myelinated fibers at 8 mo after repair
(Sterne et al., 1997
). By comparison, the muscles in the
NG group had regained some 70% of their original mass
at 4 mo. However, the benefit did not progress, remaining
unchanged up to 8 mo postoperatively. This level of recovery is similar to that reported after nerve transection and
muscle reinnervation (Gillespie et al., 1987
; Bertelli et al.,
1995), though nerve crush injury, with the preservation of
Schwann cell basal lamina tubes, results in greater muscle recovery (Bertelli et al., 1995).
The mechanism by which NT-3 exerts its effect on muscle is uncertain. NT-3 may act directly on motoneurons,
for example by enhancing survival (Eriksson et al., 1994;
Lefebvre et al., 1994
) or stimulating axonal branching
(Schnell et al., 1994
; Isaacson et al., 1996
). This might explain the increased number of myelinated axons previously
observed in NT-3-treated animals (Sterne et al., 1997
), which
in turn may lead to reinnervation of greater numbers of
muscle fibers. Alternatively, NT-3 may be acting via muscle afferent innervation. Recent studies have shown that in
transgenic mice, NT-3 overexpression in muscle influences
the survival of proprioceptive sensory neurons (Ozaki et al.,
1996
; Henderson et al., 1996
) and increases the number of
muscle spindles in gastrocnemius muscle without an overall increase in motoneuron numbers (Wright et al., 1996
).
Consistently, deletion of NT-3 during development results
in a decreased survival of muscle sensory afferents during development (Ernfors et al., 1994
; Kucera et al., 1995a
,b;
Oakley et al., 1995
). It may be possible that after nerve injury, the survival or enhanced regeneration effect of NT-3
on this subpopulation of neurons leads to a greater reinnervation of muscle spindles and Golgi tendon organs,
consequently resulting in improved sensory feedback from
the muscle. This in turn would result in greater use of the
muscle and hence lead to improvement in muscle mass.
Our data show that there are specific and highly significant effects of both nerve graft and NT-3 treatment upon type 1 and 2b muscle fibers, respectively. Nerve graft, by the nature of it, offers the regenerating nerve an almost ideal environment because of the presence of activated Schwann cells and a scaffolding of basal lamina to facilitate the progression of regenerating axons. However, treatment by nerve graft normalized type 1 fiber size but did not bring their proportion back to normal, while NT-3 treatment normalized both size and proportion. It should be remembered that we were unable to analyze MHCx/d, and therefore we cannot say if the increase in muscle mass seen in the NG group was also the result of the presence of large and numerous IIx/d fibers.
After reinnervation, morphometric analysis showed that
the diameter distribution of type 2b fibers showed a pattern similar to normal only in the NT group. Furthermore,
the general trend for the other fiber types in all experimental groups showed a shift to smaller diameter sizes.
Analysis of the proportion of different muscle fiber types
in each group at 8 mo postoperatively revealed a generalized reduction of type 1 fibers and a significant increase of
type 2a fibers. By contrast, the proportion of type 2b muscle fibers was restored to normal only in the NT group. This result is consistent with the enhanced diameters of
type 2b fibers in NT-3-treated animals, which uniquely return to the same size as in normal muscle. This result is
strongly indicative that NT-3 applied to the cut nerve may
influence the regeneration of a physiologically distinct
subset of motor neurons supplying type 2b muscle fibers.
While functional assessment of NT-3-enhanced reinnervated muscles has yet to be performed, it is known that for
reinnervated muscle, as in normal muscle, force generated is proportional to cross-sectional area of muscle fibers
(Schantz et al., 1983; Davis et al., 1988
; Totosy de Zepetnek et al., 1992
) and increase in diameter and proportion
of 2b fibers seen in the NT group is likely to result in increased force generation.
In conclusion, we have demonstrated that NT-3 enhancement of peripheral nerve regeneration does have a beneficial biochemical and morphological effect on the reinnervation of motor target organs, supporting the hypothesis of a specific phenotypic effect of growth factor-enhanced nerve regeneration. This is the first indication of a differential effect of NT-3 on neuromuscular interaction in normal adult animals in vivo. It seems doubtful that muscle reinnervation alone may be able to provoke a selective response from the muscle fibers, and it is likely that a more complex signaling system, possibly involving neurotrophic factors, may be involved. This still awaits clarification, but these results also suggest the remarkable possibility that other subpopulations of motoneurons, as classified by the phenotype they confer on muscle fibers, may be differentially responsive to other neurotrophic factors, and this leads us to believe that single or combined application of trophic factors might prove of future therapeutic value.
Received for publication 17 April 1997 and in revised form 14 August 1997.
1. Abbreviations used in this paper: ANOVA, analysis of variance; FN, fibronecin mats; MHC, myosin heavy chain; NG, autologous nerve grafts; NT-3, neurotrophin-3.The authors are grateful to The Geoffrey Burton Trust, Smith's Charity, and Glaxo Holdings for financial support.
1. | Airaksinen, M.S., M. Koltzenburg, G.R. Lewin, Y. Masu, C Helbig, E. Wolf, G. Brem, K.V. Toyka, H. Thoenen, and M. Meyer. 1996. Specific subtypes of cutaneous mechanoreceptors require neurotrophin-3 following peripheral target innervation. Neuron. 16: 287-295 |
2. | Averbuch-Heller, L., M. Pruginin, N. Kahane, T. Pantelis, L. Parada, A. Rosenthal, and C. Kalcheim. 1994. Neurotrophin 3 stimulates the differentiation of motoneurons from avian neural tube progenitor cells. Proc. Natl. Acad. Sci. USA. 91: 3247-3251 [Abstract]. |
3. | Bar, A., and D. Pette. 1988. Three fast myosin heavy chains in adult rat skeletal muscle. FEBS Lett. 235: 153-155 |
4. | Bertelli, J.A., and J.C. Mira. 1995. The grasping test: a simple behavioral method for objective quantitative assessment of peripheral nerve regeneration in the rat. J. Neurosci. Methods. 58: 151-155 |
5. | Braun, S., B. Croizat, M.C. Lagrange, J.M. Warter, and P. Poindron. 1996. Neurotrophins increase motorneurons ability to innervate skeletal muscle fibers in rat spinal cord-human muscle cocultures. J. Neurol. Sci. 136: 17-23 |
6. | Burke, R.E., D.E. Levine, F.E. Zajac, P. Tsairis, and W.K. Engel. 1971. Mammalian motor units: physiological histochemical correlation in three types in cat gastrocnemius. Science (Wash. DC). 174: 709-712 |
7. | Davis, H.L., B.H. Bressler, and L.G. Jasch. 1988. Myotrophic effects on denervated fast-twitch muscles of mice: correlation of physiologic, biochemical, and morphologic findings. Exp. Neurol. 99: 474-489 |
8. | DiStefano, P.S., B. Friedman, C. Radziejewski, C. Alexander, P. Boland, C.M. Schick, R.M. Lindsay, and S.J. Wiegard. 1992. The neurotrophins BDNF, NT-3 and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron. 8: 983-993 |
9. | Eriksson, N.P., R.M. Lindsay, and H. Aldskogius. 1994. BDNF and NT-3 rescue sensory but not motoneurons following axotomy in the neonate. Neuroreport. 5: 1445-1448 |
10. | Ernfors, P., K.F. Lee, J. Kucera, and R. Jaenisch. 1994. Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell. 77: 503-512 |
11. | Fex, S., and B. Sonneson. 1970. Histochemical observations after implantation of a `fast' nerve into an innervated mammalian `slow' skeletal muscle. Acta Anat. 77: 1-5 |
12. | Fields, R.D., and M.H. Ellisman. 1986. Axons regenerating through silicone tube splices 2. Functional morphology. Exp. Neurol. 92: 61-74 |
13. |
Gillespie, M.J.,
T. Gordon, and
P.R. Murphy.
1987.
Motor units and histochemistry in rat lateral gastrocnemius and soleus muscles: evidence for dissociation of physiological and histochemical properties after reinnervation.
J.
Neurophysiol.
57:
921-937
|
14. |
Goldspink, G.,
A. Scutt,
P.T. Loughna,
D.J. Wells,
T. Jaenicke, and
G.F. Gerlach.
1992.
Gene expression in skeletal muscle in response to stretch and
force generation.
Am. J. Physiol.
262:
R356-363
|
15. | Green, H.J., H. Reichmann, and D. Pette. 1983. Fibre type specific transformations in the enzyme activity pattern of rat vastus lateralis muscle by prolonged endurance training. Pfleug. Arch. Eur. J. Physiol. 399: 216-222 |
16. | Griesbeck, O., A.S. Parsadanian, M. Sendtner, and H. Thoenen. 1995. Expression of neurotrophins in skeletal muscle: quantitative comparison and significance for motoneuron survival and maintenance of function. J. Neurosci. Res. 42: 21-33 |
17. | Henderson, C.E., W. Camu, C. Mettling, A. Gouin, K. Poulsen, M. Karihaloo, J. Rullamas, T. Evans, S.B. McMahon, M.P. Armanini, et al . 1993. Neurotrophins promote motor neuron survival and are present in embryonic limb buds. Nature (Lond.). 363: 266-270 |
18. | Henderson, T.A., D.E. Wright, W.D. Snider, and M.F. Jacquin. 1996. Effects of NT-3 overexpression in muscle on the trigeminal mesencephalic nucleus. Soc. Neurosci. 22: 999 . |
19. | Hughes, R.A., M. Sendtner, and H. Thoenen. 1993. Members of several gene families influence survival of rat motoneurons in vitro and in vivo. J. Neurosci. Res. 36: 663-671 |
20. | Isaacson, L.G., B.N. Saffran, and K.A. Crutcher. 1996. Nerve growth factor- induced sprouting of mature uninjured sympathetic axons. J. Comp. Neurol. 326: 327-336 . |
21. | Izumo, S., B. Nadal-Ginard, and B. Mahdavi. 1986. All members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science (Wash. DC). 231: 597-600 |
22. | Jansson, E., B. Sjodin, and P. Tesch. 1978. Changes in muscle fibre type distribution in man after physical training. A sign of fibre type transformation? Acta Physiol. Scand. 104: 235-237 |
23. | Karpati, G., and W.K. Engel. 1968. `Type grouping' in skeletal muscles after experimental reinnervation. Neurology. 18: 447-449 |
24. | Kato, A.C., and R.M. Lindsay. 1994. Overlapping and additive effects of neurotrophins and CNTF on cultured human spinal cord neurons. Exp. Neurol. 130: 196-201 |
25. | Kucera, J., P. Ernfors, J. Walro, and R. Jaenisch. 1995a. Reduction in the number of spinal motor neurons in neurotrophin-3-deficient mice. Neuroscience. 69: 321-330 |
26. | Kucera, J., G.P. Fan, R. Jaenisch, S. Linnarsson, and P. Ernfors. 1995b. Dependence of developing group Ia afferents on neurotrophin-3. J. Comp. Neurol. 363: 307-320 |
27. | Lefebvre, P.P., B. Malgrange, H. Staeker, M. Moghadass, T.R. Van de Water, and G. Moonen. 1994. Neurotrophins affect survival and neuritogenesis by adult injured auditory neurons in vitro. Neuroreport. 5: 865-858 |
28. | Lewin, G.R., and Y.A. Barde. 1996. Physiology of the neurotrophins. Annu. Rev. Neurosci. 19: 289-317 |
29. | Li, L., R.W. Oppenheim, M. Lei, and L.J. Houenou. 1994. Neurotrophic agents prevent motoneuron death following sciatic nerve section in the neonatal mouse. J. Neurobiol. 25: 759-766 |
30. | Lindsay, R.M.. 1996. Role of neurotrophins and trk receptors in the development and maintenance of sensory neurons: An overview. Philos. Trans. R. Soc. Lond. Biol. Sci 351: 365-73 |
31. | Lohof, A.M., N.Y. Ip, and M. Poo. 1993. Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature (Lond.). 363: 350-353 |
32. |
Maltin, C.A.,
M.I. Delday,
G.S. Baillie,
D.A. Grubb, and
P.J. Garlick.
1989.
Fibre type composition of nine rat muscles I. Changes in the first year of life.
Am. J. Physiol.
257:
E823-827
|
33. |
Oakley, R.A.,
A.S. Garner,
T.H. Large, and
E. Frank.
1995.
Muscle sensory
neurons require neurotrophin-3 from peripheral tissues during the period of
normal cell death.
Development (Camb.).
121:
1341-1350
|
34. | Ozaki, S., D.E. Wright, L. Zhou, and W.D. Snider. 1996. Influences of NT-3 on proprioceptive axon projections to spinal motoneuron pools. Soc. Neurosci. 22: 1000 . |
35. |
Pellegrino, C., and
C. Franzini.
1963.
An electron microscope study of denervation atrophy in red and white skeletal muscle fibers.
J. Cell Biol.
17:
327-332
|
36. | Peter, J.B., R.J. Barnard, V.R. Edgerton, C.A. Gillespie, and K.E. Stemper. 1972. Metabolic profiles of three fibre types of skeletal muscle in guinea pigs and rabbits. Biochemistry. 11: 2627-2633 |
37. | Pette, D., and G. Vrbova. 1992. Adaptation of mammalian skeletal muscle fibres to chronic electrical stimulation. Rev. Physiol. Biochem. Pharmacol. 120: 115-120 |
38. | Romanul, F.C.A., and J.P. Van der Meulen. 1966. Reversal of the enzyme profiles in fast and slow muscles by cross innervation. Nature (Lond.). 212: 1369-1371 |
39. | Salmons, S., and F.A. Sreter. 1975. The role of impulse activity in the transformation of skeletal muscle by cross innervation. J. Anat. 120: 412-415 . |
40. | Schantz, P., E. Randall-Fox, W. Hutchison, A. Tyden, and P.O. Astrand. 1983. Muscle fibre type distribution, muscle cross-sectional area and maximal voluntary strength in humans. Acta Physiol. Scand. 117: 219-226 |
41. | Schiaffino, S., L. Gorza, S. Sartore, L. Saggin, S. Ausoni, M. Vianello, K. Gundersen, and T. Lomo. 1989. Three myosin heavy chain isoforms in type 2 skeletal muscle fibres. J. Muscle. Res. Cell Motil. 10: 197-205 |
42. | Schnell, L., R. Schneider, R. Kolbeck, Y. Barde, and M.E. Schwab. 1994. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion. Nature (Lond.). 367: 170-173 |
43. | Sterne, G.D., R.A. Brown, C.J. Green, and G. Terenghi. 1997. Neurotrophin-3 delivered locally via fibronectin mats enhances peripheral nerve regeneration. Eur. J. Neurosci. 9: 1388-1396 |
44. | Sunderland, S. 1978. Morphological changes in striated muscle due to denervation. Atrophy. In Nerves and Nerve Injures. 2nd ed. Churchill Livingstone, Edinburgh, Scotland. 229-245. |
45. |
Tessarollo, L.,
K.S. Vogel,
M.E. Palko,
S.W. Reid, and
L.F. Parada.
1994.
Targeted mutation in the neurotrophin-3 gene results in loss of muscle sensory
neurons.
Proc. Natl. Acad. Sci. USA.
91:
11844-11848
|
46. |
Totosy de Zepetnek, J.E.,
H.V. Zung,
S. Erdebil, and
T. Gordon.
1992.
Innervation ratio is an important determinant of force in normal and reinnervated
rat tibialis anterior muscles.
J. Neurophysiol.
67:
1385-1403
|
47. | Vejsada, R., Y. Sagot, and A.C. Kato. 1995. Quantitative comparison of the transient rescue effects of neurotrophic factors on axotomized motoneurons in vivo. Eur. J. Neurosci. 7: 108-115 |
48. | Wang, T., K. Xie, and B. Lu. 1995. Neurotrophins promote maturation of developing neuromuscular synapses. J. Neurosci. 15: 4796-4805 [Abstract]. |
49. | Wong, V., R. Arriaga, N.Y. Ip, and R.M. Lindsay. 1993. The neurotrophins BDNF, NT-3 and NT-4/5, but not NGF, up-regulate the cholinergic phenotype of developing motor neurons. Eur. J. Neurosci. 5: 466-474 |
50. | Wright, D.E., L. Zhou, J. Harding, and W.D. Snider. 1996. Overexpression of NT-3 in muscle stimulates the formation of supernumerary muscle spindles. Soc. Neurosci. 22: 512 . |